{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:44Z","timestamp":1786985084639,"version":"build-2736575974"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31801006"],"award-info":[{"award-number":["31801006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32100920"],"award-info":[{"award-number":["32100920"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515012678"],"award-info":[{"award-number":["2023A1515012678"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117238","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:09:37Z","timestamp":1755493777000},"page":"117238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["20-HETE: Its potential role in physiological and pathophysiological processes"],"prefix":"10.1016","volume":"242","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5411-4334","authenticated-orcid":false,"given":"Yu-Ning","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-yu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117238_b0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2015.05.002","article-title":"Cytochrome P450 omega-Hydroxylases in Inflammation and Cancer","volume":"74","author":"Johnson","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"478","key":"10.1016\/j.bcp.2025.117238_b0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.abb.2008.06.025","article-title":"Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies","volume":"1","author":"Hirani","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"issue":"281","key":"10.1016\/j.bcp.2025.117238_b0015","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1074\/jbc.M513101200","article-title":"Cytochrome P-450 4F18 is the leukotriene B4 omega-1\/omega-2 hydroxylase in mouse polymorphonuclear leukocytes: identification as the functional orthologue of human polymorphonuclear leukocyte CYP4F3A in the down-regulation of responses to LTB4","volume":"11","author":"Christmas","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"276","key":"10.1016\/j.bcp.2025.117238_b0020","doi-asserted-by":"crossref","first-page":"38166","DOI":"10.1074\/jbc.M104818200","article-title":"Alternative splicing determines the function of CYP4F3 by switching substrate specificity","volume":"41","author":"Christmas","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"409","key":"10.1016\/j.bcp.2025.117238_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0003-9861(02)00511-8","article-title":"Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions","volume":"1","author":"Stark","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"issue":"49","key":"10.1016\/j.bcp.2025.117238_b0030","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1194\/jlr.M700450-JLR200","article-title":"Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11","volume":"3","author":"Dhar","year":"2008","journal-title":"J. Lipid Res."},{"issue":"75","key":"10.1016\/j.bcp.2025.117238_b0035","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.bcp.2008.03.004","article-title":"Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases","volume":"12","author":"Hardwick","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"274","key":"10.1016\/j.bcp.2025.117238_b0040","first-page":"F395","article-title":"Localization of cytochrome P-450 4A isoforms along the rat nephron","volume":"2","author":"Ito","year":"1998","journal-title":"Am. J. Phys. Anthropol."},{"issue":"276","key":"10.1016\/j.bcp.2025.117238_b0045","first-page":"R1691","article-title":"Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors","volume":"6","author":"Nguyen","year":"1999","journal-title":"Am. J. Phys. Anthropol."},{"issue":"308","key":"10.1016\/j.bcp.2025.117238_b0050","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1124\/jpet.103.059626","article-title":"Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes","volume":"3","author":"Xu","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"412","key":"10.1016\/j.bcp.2025.117238_b0055","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0003-9861(03)00030-4","article-title":"Leukotriene B4 omega-side chain hydroxylation by CYP4F5 and CYP4F6","volume":"1","author":"Bylund","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"issue":"403","key":"10.1016\/j.bcp.2025.117238_b0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BJ20061328","article-title":"Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation","volume":"1","author":"Muller","year":"2007","journal-title":"Biochem. J"},{"issue":"69","key":"10.1016\/j.bcp.2025.117238_b0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5650\/jos.ess20080","article-title":"CYP4F13 is the major enzyme for conversion of alpha-eleostearic acid into cis-9, trans-11-conjugated linoleic acid in mouse hepatic microsomes","volume":"9","author":"Wu","year":"2020","journal-title":"J. Oleo Sci."},{"issue":"383","key":"10.1016\/j.bcp.2025.117238_b0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/abbi.2000.2078","article-title":"Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14","volume":"2","author":"Kikuta","year":"2000","journal-title":"Arch. Biochem. Biophys."},{"issue":"111","key":"10.1016\/j.bcp.2025.117238_b0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.CIR.0000151309.82473.59","article-title":"Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension","volume":"1","author":"Gainer","year":"2005","journal-title":"Circulation"},{"issue":"51","key":"10.1016\/j.bcp.2025.117238_b0080","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/HYPERTENSIONAHA.107.104463","article-title":"A single nucleotide polymorphism in the CYP4F2 but not CYP4A11 gene is associated with increased 20-HETE excretion and blood pressure","volume":"5","author":"Ward","year":"2008","journal-title":"Hypertension"},{"issue":"30","key":"10.1016\/j.bcp.2025.117238_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1152\/physiolgenomics.00003.2007","article-title":"Functional polymorphism in human CYP4F2 decreases 20-HETE production","volume":"1","author":"Stec","year":"2007","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.bcp.2025.117238_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.plefa.2018.02.003","article-title":"Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)","volume":"131","author":"Kim","year":"2018","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"52","key":"10.1016\/j.bcp.2025.117238_b0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/HYPERTENSIONAHA.108.114199","article-title":"The V433M variant of the CYP4F2 is associated with ischemic stroke in male Swedes beyond its effect on blood pressure","volume":"2","author":"Fava","year":"2008","journal-title":"Hypertension"},{"issue":"21","key":"10.1016\/j.bcp.2025.117238_b0100","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/ajh.2008.276","article-title":"A haplotype of the CYP4F2 gene is associated with cerebral infarction in Japanese men","volume":"11","author":"Fu","year":"2008","journal-title":"Am. J. Hypertens."},{"issue":"20","key":"10.1016\/j.bcp.2025.117238_b0105","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/gtmb.2015.0205","article-title":"Interaction between CYP4F2 rs2108622 and CPY4A11 rs9333025 Variants is significantly Correlated with Susceptibility to Ischemic Stroke and 20-Hydroxyeicosatetraenoic Acid Level","volume":"5","author":"Liao","year":"2016","journal-title":"Genet. Test. Mol. Biomark."},{"issue":"311","key":"10.1016\/j.bcp.2025.117238_b0110","doi-asserted-by":"crossref","first-page":"F71","DOI":"10.1152\/ajprenal.00458.2015","article-title":"20-HETE and CYP4A2 omega-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats","volume":"1","author":"Dalmasso","year":"2016","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"152","key":"10.1016\/j.bcp.2025.117238_b0115","article-title":"20-HETE interferes with insulin signaling and contributes to obesity-driven insulin resistance","author":"Gilani","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"319","key":"10.1016\/j.bcp.2025.117238_b0120","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1152\/ajpregu.00089.2020","article-title":"Proximal tubular-targeted overexpression of the Cyp4a12-20-HETE synthase promotes salt-sensitive hypertension in male mice","volume":"1","author":"Gilani","year":"2020","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"issue":"101","key":"10.1016\/j.bcp.2025.117238_b0125","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1139\/cjpp-2023-0014","article-title":"Sex- and enantiospecific differences in the formation rate of hydroxyeicosatetraenoic acids in rat organs","volume":"8","author":"Gerges","year":"2023","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"363","key":"10.1016\/j.bcp.2025.117238_b0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1124\/jpet.117.243618","article-title":"The blood pressure-lowering effect of 20-HETE blockade in Cyp4a14(-\/-) mice is associated with natriuresis","volume":"3","author":"Pandey","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"161","key":"10.1016\/j.bcp.2025.117238_b0135","article-title":"Sexual dimorphism in renal heme oxygenase-1 and arachidonic acid metabolizing enzymes in spontaneously hypertensive rats versus normotensive Wistar Kyoto rats","author":"Alhashim","year":"2022","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"19","key":"10.1016\/j.bcp.2025.117238_b0140","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/01.aids.0000180789.00251.03","article-title":"Concealment of HIV and unsafe sex with steady partner is extremely infrequent","volume":"13","author":"Spire","year":"2005","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.bcp.2025.117238_b0145","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fphys.2018.00490","article-title":"Detrimental Effects of Testosterone Addition to Estrogen Therapy Involve Cytochrome P-450-Induced 20-HETE Synthesis in Aorta of Ovariectomized Spontaneously Hypertensive Rat (SHR), a Model of Postmenopausal Hypertension","author":"Costa","year":"2018","journal-title":"Front. Physiol."},{"issue":"264","key":"10.1016\/j.bcp.2025.117238_b0150","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1016\/S0021-9258(18)80115-6","article-title":"Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase. Formation and identification of novel endothelium-dependent vasoconstrictor metabolites","volume":"20","author":"Schwartzman","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.117238_b0155","article-title":"Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"1","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"issue":"280","key":"10.1016\/j.bcp.2025.117238_b0160","doi-asserted-by":"crossref","first-page":"33157","DOI":"10.1074\/jbc.M504055200","article-title":"Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4","volume":"39","author":"Collins","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"82","key":"10.1016\/j.bcp.2025.117238_b0165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.prostaglandins.2006.05.002","article-title":"20-carboxy-arachidonic acid is a dual activator of peroxisome proliferator-activated receptors alpha and gamma","volume":"1\u20134","author":"Fang","year":"2007","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"279","key":"10.1016\/j.bcp.2025.117238_b0170","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1074\/jbc.M306849200","article-title":"20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells","volume":"4","author":"Kaduce","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"120","key":"10.1016\/j.bcp.2025.117238_b0175","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/CIRCRESAHA.116.310525","article-title":"20-HETE Signals through G-Protein-Coupled Receptor GPR75 (G(q)) to Affect Vascular Function and Trigger Hypertension","volume":"11","author":"Garcia","year":"2017","journal-title":"Circ. Res."},{"issue":"81","key":"10.1016\/j.bcp.2025.117238_b0180","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/HYPERTENSIONAHA.124.21718","article-title":"20-HETE and Hypertension","volume":"10","author":"Roman","year":"2024","journal-title":"Hypertension"},{"issue":"9","key":"10.1016\/j.bcp.2025.117238_b0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-017-02539-4","article-title":"20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1","volume":"1","author":"Tunaru","year":"2018","journal-title":"Nat. Commun."},{"issue":"192","key":"10.1016\/j.bcp.2025.117238_b0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pharmthera.2018.07.004","article-title":"20-HETE in the regulation of vascular and cardiac function","author":"Rocic","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"248","key":"10.1016\/j.bcp.2025.117238_b0195","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0022-3565(25)23636-9","article-title":"Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase","volume":"1","author":"Escalante","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"41","key":"10.1016\/j.bcp.2025.117238_b0200","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1161\/01.HYP.0000047240.33861.6B","article-title":"20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase","volume":"2","author":"Randriamboavonjy","year":"2003","journal-title":"Hypertension, 3 Pt"},{"issue":"33","key":"10.1016\/j.bcp.2025.117238_b0205","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.HYP.33.1.414","article-title":"Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles","volume":"1 Pt 2","author":"Sun","year":"1999","journal-title":"Hypertension"},{"issue":"65","key":"10.1016\/j.bcp.2025.117238_b0210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-6980(01)00112-5","article-title":"Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells","volume":"1","author":"Muthalif","year":"2001","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"19","key":"10.1016\/j.bcp.2025.117238_b0215","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099200","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells","volume":"1\u20134","author":"Stec","year":"2007","journal-title":"Cell. Physiol. Biochem."},{"issue":"166","key":"10.1016\/j.bcp.2025.117238_b0220","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0002-9440(10)62282-1","article-title":"Inhibitors of cytochrome P450 4A suppress angiogenic responses","volume":"2","author":"Chen","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"28","key":"10.1016\/j.bcp.2025.117238_b0225","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1096\/fj.13-241927","article-title":"Vascular characterization of mice with endothelial expression of cytochrome P450 4F2","volume":"7","author":"Cheng","year":"2014","journal-title":"FASEB J."},{"issue":"83","key":"10.1016\/j.bcp.2025.117238_b0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.vph.2016.04.002","article-title":"20-HETE contributes to ischemia-induced angiogenesis","author":"Chen","year":"2016","journal-title":"Vasc. Pharmacol."},{"issue":"321","key":"10.1016\/j.bcp.2025.117238_b0235","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1124\/jpet.106.115360","article-title":"Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation","volume":"1","author":"Guo","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"338","key":"10.1016\/j.bcp.2025.117238_b0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/jpet.111.179036","article-title":"The cytochrome P450 4A\/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood","volume":"2","author":"Guo","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"348","key":"10.1016\/j.bcp.2025.117238_b0245","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/jpet.113.210120","article-title":"20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo","volume":"3","author":"Chen","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"38","key":"10.1016\/j.bcp.2025.117238_b0250","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1440-1681.2011.05509.x","article-title":"Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction","volume":"5","author":"Ward","year":"2011","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"332","key":"10.1016\/j.bcp.2025.117238_b0255","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1124\/jpet.109.159863","article-title":"20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling","volume":"1","author":"Cheng","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"32","key":"10.1016\/j.bcp.2025.117238_b0260","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"8","author":"Cheng","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"356","key":"10.1016\/j.bcp.2025.117238_b0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/jpet.115.229377","article-title":"20-HETE activates the transcription of angiotensin-converting enzyme via nuclear factor-kappaB translocation and promoter binding","volume":"3","author":"Garcia","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"9","key":"10.1016\/j.bcp.2025.117238_b0270","article-title":"20-Hydroxyeicosatetraenoic acid impairs endothelial insulin signaling by inducing phosphorylation of the insulin receptor substrate-1 at Ser616","volume":"4","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"806","key":"10.1016\/j.bcp.2025.117238_b0275","article-title":"Fine particulate matter and vasoactive 20-hydroxyeicosatetraenoic acid: Insights into the mechanisms of the prohypertensive effects of particulate air pollution","volume":"3","author":"Wang","year":"2022","journal-title":"Sci. Total Environ., Pt"},{"issue":"11","key":"10.1016\/j.bcp.2025.117238_b0280","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/ckj\/sfx153","article-title":"Is renal tubular cadmium toxicity clinically relevant?","volume":"5","author":"Boonprasert","year":"2018","journal-title":"Clin. Kidney J."},{"issue":"32","key":"10.1016\/j.bcp.2025.117238_b0285","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/HJH.0000000000000208","article-title":"The effect of a single nucleotide polymorphism of the CYP4F2 gene on blood pressure and 20-hydroxyeicosatetraenoic acid excretion after weight loss","volume":"7","author":"Ward","year":"2014","journal-title":"J. Hypertens."},{"issue":"134","key":"10.1016\/j.bcp.2025.117238_b0290","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.prostaglandins.2017.09.004","article-title":"Selective inhibition of 20-hydroxyeicosatetraenoic acid lowers blood pressure in a rat model of preeclampsia","author":"Faulkner","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"13","key":"10.1016\/j.bcp.2025.117238_b0295","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4238\/2014.January.21.20","article-title":"Association of a CYP4A11 polymorphism and hypertension in the Mongolian and Han populations of China","volume":"1","author":"Liang","year":"2014","journal-title":"Genet. Mol. Res."},{"issue":"51","key":"10.1016\/j.bcp.2025.117238_b0300","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/HYPERTENSIONAHA.107.105395","article-title":"Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease","volume":"5","author":"Minuz","year":"2008","journal-title":"Hypertension"},{"issue":"38","key":"10.1016\/j.bcp.2025.117238_b0305","article-title":"20-Hydroxyeicosatetraenoic acid antagonist attenuates the development of malignant hypertension and reverses it once established: a study in Cyp1a1-Ren-2 transgenic rats","volume":"5","author":"Sedlakova","year":"2018","journal-title":"Biosci. Rep."},{"issue":"12","key":"10.1016\/j.bcp.2025.117238_b0310","article-title":"Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats","author":"Walkowska","year":"2021","journal-title":"Front. Physiol."},{"issue":"38","key":"10.1016\/j.bcp.2025.117238_b0315","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/HJH.0000000000002462","article-title":"Combined treatment with epoxyeicosatrienoic acid analog and 20-hydroxyeicosatetraenoic acid antagonist provides substantial hypotensive effect in spontaneously hypertensive rats","volume":"9","author":"Gawrys","year":"2020","journal-title":"J. Hypertens."},{"issue":"40","key":"10.1016\/j.bcp.2025.117238_b0320","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/HJH.0000000000003038","article-title":"Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase","volume":"3","author":"Agostinucci","year":"2022","journal-title":"J. Hypertens."},{"issue":"17","key":"10.1016\/j.bcp.2025.117238_b0325","first-page":"525","article-title":"Modulation by cytochrome P450-4A omega-hydroxylase enzymes of adrenergic vasoconstriction and response to reduced PO(2) in mesenteric resistance arteries of Dahl salt-sensitive rats","volume":"7","author":"Raffai","year":"2010","journal-title":"Microcirculation"},{"issue":"324","key":"10.1016\/j.bcp.2025.117238_b0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.107.130336","article-title":"20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells","volume":"1","author":"Ishizuka","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"139","key":"10.1016\/j.bcp.2025.117238_b0335","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prostaglandins.2018.09.003","article-title":"Angiotensin II upregulates CYP4A isoform expression in the rat kidney through angiotensin II type 1 receptor","author":"Rong","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"28","key":"10.1016\/j.bcp.2025.117238_b0340","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/ajh\/hpu201","article-title":"Azilsartan is associated with increased circulating angiotensin-(1-7) levels and reduced renovascular 20-HETE levels","volume":"5","author":"Carroll","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"12","key":"10.1016\/j.bcp.2025.117238_b0345","article-title":"Epoxyeicosatrienoic acid analog and 20-HETE antagonist combination prevent hypertension development in spontaneously hypertensive rats","author":"Baranowska","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"353","key":"10.1016\/j.bcp.2025.117238_b0350","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.amjms.2017.04.009","article-title":"Fenofibrate Attenuates Hypertension in Goldblatt Hypertensive Rats: Role of 20-Hydroxyeicosatetraenoic Acid in the Nonclipped Kidney","volume":"6","author":"Sporkova","year":"2017","journal-title":"Am. J. Med. Sci."},{"issue":"308","key":"10.1016\/j.bcp.2025.117238_b0355","doi-asserted-by":"crossref","first-page":"R379","DOI":"10.1152\/ajpregu.00256.2014","article-title":"Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat","volume":"5","author":"Fan","year":"2015","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"issue":"21","key":"10.1016\/j.bcp.2025.117238_b0360","article-title":"The antihypertensive effect of quercetin in young spontaneously hypertensive rats; role of arachidonic acid metabolism","volume":"18","author":"Elbarbry","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.bcp.2025.117238_b0365","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000368508","article-title":"High salt intake increases blood pressure in normal rats: putative role of 20-HETE and no evidence on changes in renal vascular reactivity","volume":"3","author":"Walkowska","year":"2015","journal-title":"Kidney Blood Pressure Res."},{"issue":"100\u2013101","key":"10.1016\/j.bcp.2025.117238_b0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.prostaglandins.2012.12.002","article-title":"Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia","author":"Issan","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"13","key":"10.1016\/j.bcp.2025.117238_b0375","article-title":"Targeted metabolomic approach in men with carotid plaque","volume":"7","author":"Auguet","year":"2018","journal-title":"PLoS One"},{"issue":"302","key":"10.1016\/j.bcp.2025.117238_b0380","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1152\/ajpendo.00370.2011","article-title":"Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism","volume":"5","author":"Theken","year":"2012","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"issue":"312","key":"10.1016\/j.bcp.2025.117238_b0385","doi-asserted-by":"crossref","first-page":"H528","DOI":"10.1152\/ajpheart.00561.2016","article-title":"Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction","volume":"3","author":"Joseph","year":"2017","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"315","key":"10.1016\/j.bcp.2025.117238_b0390","doi-asserted-by":"crossref","first-page":"R934","DOI":"10.1152\/ajpregu.00125.2018","article-title":"High-fat diet-induced obesity and insulin resistance in CYP4a14(-\/-) mice is mediated by 20-HETE","volume":"5","author":"Gilani","year":"2018","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117238_b0395","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1096\/fasebj.10.11.8836037","article-title":"Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation","volume":"11","author":"Johnson","year":"1996","journal-title":"FASEB J."},{"issue":"373","key":"10.1016\/j.bcp.2025.117238_b0400","article-title":"Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity","volume":"6550","author":"Akbari","year":"2021","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.bcp.2025.117238_b0405","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/oby.23692","article-title":"Gpr75-deficient mice are protected from high-fat diet-induced obesity","volume":"4","author":"Hossain","year":"2023","journal-title":"Obesity"},{"issue":"165","key":"10.1016\/j.bcp.2025.117238_b0410","article-title":"The frequency of cytochrome 4F2 rs2108622 genetic variant and its effects on the lipid profile and complications of type II diabetes among a sample of patients in Jordan: a pilot study","author":"Jarrar","year":"2023","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"40","key":"10.1016\/j.bcp.2025.117238_b0415","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1097\/HJH.0000000000003253","article-title":"Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia","volume":"11","author":"Barden","year":"2022","journal-title":"J. Hypertens."},{"issue":"235","key":"10.1016\/j.bcp.2025.117238_b0420","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.trsl.2021.03.010","article-title":"Pharmacological regulation of cytochrome P450 metabolites of arachidonic acid attenuates cardiac injury in diabetic rats","author":"Alaeddine","year":"2021","journal-title":"Transl. Res."},{"issue":"23","key":"10.1016\/j.bcp.2025.117238_b0425","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2022.02.011","article-title":"Activation of 20-HETE synthase triggers oxidative injury and peripheral nerve damage in type 2 diabetic mice","volume":"8","author":"Haddad","year":"2022","journal-title":"J. Pain"},{"key":"10.1016\/j.bcp.2025.117238_b0430","doi-asserted-by":"crossref","unstructured":"E.T. McCarthy, J. Zhou, R. Eckert, D. Genochio, R. Sharma, O. Oni, et al. Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE. Prostaglandins Other Lipid Mediat., (116-117) (2015), p.88-98.","DOI":"10.1016\/j.prostaglandins.2014.10.006"},{"issue":"7","key":"10.1016\/j.bcp.2025.117238_b0435","first-page":"351","article-title":"20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes","author":"Roshanravan","year":"2016","journal-title":"Front. Physiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117238_b0440","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1038\/s41598-020-59663-3","article-title":"Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome","volume":"1","author":"Tatarunas","year":"2020","journal-title":"Sci. Rep."},{"issue":"54","key":"10.1016\/j.bcp.2025.117238_b0445","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12020-016-1031-5","article-title":"20-HETE attenuates the response of glucose-stimulated insulin secretion through the AKT\/GSK-3beta\/Glut2 pathway","volume":"2","author":"Zhang","year":"2016","journal-title":"Endocrine"},{"issue":"65","key":"10.1016\/j.bcp.2025.117238_b0450","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s10620-020-06095-8","article-title":"Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease","volume":"12","author":"Li","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"29","key":"10.1016\/j.bcp.2025.117238_b0455","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1248\/bpb.29.1634","article-title":"Changes in the expression of cytochromes P450 and nuclear receptors in the liver of genetically diabetic db\/db mice","volume":"8","author":"Yoshinari","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"147","key":"10.1016\/j.bcp.2025.117238_b0460","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.gastro.2014.06.039","article-title":"Inhibition of CYP4A reduces hepatic endoplasmic reticulum stress and features of diabetes in mice","volume":"4","author":"Park","year":"2014","journal-title":"Gastroenterology"},{"issue":"147","key":"10.1016\/j.bcp.2025.117238_b0465","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/en.2005-1132","article-title":"Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression","volume":"3","author":"Patsouris","year":"2006","journal-title":"Endocrinology"},{"issue":"234","key":"10.1016\/j.bcp.2025.117238_b0470","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.taap.2008.09.022","article-title":"Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice","volume":"2","author":"Gyamfi","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"114","key":"10.1016\/j.bcp.2025.117238_b0475","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1073\/pnas.1700172114","article-title":"Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis","volume":"12","author":"Zhang","year":"2017","journal-title":"PNAS"},{"issue":"373","key":"10.1016\/j.bcp.2025.117238_b0480","first-page":"1","article-title":"20-Hydroxytetraenoic acid induces hepatic fibrosis via the TGF-beta1\/Smad3 signaling pathway","author":"Li","year":"2023","journal-title":"Toxicol. Lett."},{"issue":"134","key":"10.1016\/j.bcp.2025.117238_b0485","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.prostaglandins.2017.08.005","article-title":"20-HETE regulated PSMB5 expression via TGF-beta\/Smad signaling pathway","author":"Lai","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"833","key":"10.1016\/j.bcp.2025.117238_b0490","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2018.06.010","article-title":"Conflicting roles of 20-HETE in hypertension and renal end organ damage","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"307","key":"10.1016\/j.bcp.2025.117238_b0495","doi-asserted-by":"crossref","first-page":"F509","DOI":"10.1152\/ajprenal.00273.2014","article-title":"Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats","volume":"5","author":"Ge","year":"2014","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"307","key":"10.1016\/j.bcp.2025.117238_b0500","doi-asserted-by":"crossref","first-page":"F533","DOI":"10.1152\/ajprenal.00283.2014","article-title":"Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE","volume":"5","author":"Ren","year":"2014","journal-title":"Am. J. Physiol.-Renal Physiol."},{"issue":"72","key":"10.1016\/j.bcp.2025.117238_b0505","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/HYPERTENSIONAHA.118.10269","article-title":"20-HETE: hypertension and beyond","volume":"1","author":"Roman","year":"2018","journal-title":"Hypertension"},{"issue":"1864","key":"10.1016\/j.bcp.2025.117238_b0510","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbadis.2017.12.028","article-title":"Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice","volume":"3","author":"Zhou","year":"2018","journal-title":"Biochim. Biophys. Acta-Mol. Basis Dis."},{"issue":"386","key":"10.1016\/j.bcp.2025.117238_b0515","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.122.001521","article-title":"Renoprotective effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis","volume":"1","author":"Hirata","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"26","key":"10.1016\/j.bcp.2025.117238_b0520","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"3","author":"Gangadhariah","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"issue":"382","key":"10.1016\/j.bcp.2025.117238_b0525","article-title":"Effects of PPARs\/20-HETE on the renal impairment under diabetic conditions","volume":"1","author":"Ding","year":"2019","journal-title":"Exp. Cell Res."},{"issue":"307","key":"10.1016\/j.bcp.2025.117238_b0530","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cbi.2019.05.004","article-title":"Activation of 20-HETE\/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy","author":"Ding","year":"2019","journal-title":"Chem.-Biol. Interact."},{"issue":"154","key":"10.1016\/j.bcp.2025.117238_b0535","article-title":"20-HETE-promoted cerebral blood flow autoregulation is associated with enhanced pericyte contractility","author":"Liu","year":"2021","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"124","key":"10.1016\/j.bcp.2025.117238_b0540","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.prostaglandins.2016.04.003","article-title":"Expression of CYP 4A omega-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes","author":"Gebremedhin","year":"2016","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"168","key":"10.1016\/j.bcp.2025.117238_b0545","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1111\/bph.12079","article-title":"Treatment with the cytochrome P450 omega-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats","volume":"8","author":"Toth","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"23","key":"10.1016\/j.bcp.2025.117238_b0550","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/micc.12304","article-title":"Role of vascular reactive oxygen species in regulating cytochrome P450-4A enzyme expression in Dahl salt-sensitive rats","volume":"7","author":"Lukaszewicz","year":"2016","journal-title":"Microcirculation"},{"issue":"1544","key":"10.1016\/j.bcp.2025.117238_b0555","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2013.11.031","article-title":"The protective effect of HET0016 on brain edema and blood-brain barrier dysfunction after cerebral ischemia\/reperfusion","author":"Liu","year":"2014","journal-title":"Brain Res."},{"issue":"54","key":"10.1016\/j.bcp.2025.117238_b0560","article-title":"20-HETE synthesis inhibition attenuates traumatic brain injury-induced mitochondrial dysfunction and neuronal apoptosis via the SIRT1\/PGC-1alpha pathway: a translational study","volume":"2","author":"Cui","year":"2021","journal-title":"Cell Prolif."},{"issue":"239","key":"10.1016\/j.bcp.2025.117238_b0565","article-title":"HET0016 inhibits neuronal pyroptosis in the immature brain post-TBI via the p38 MAPK signaling pathway","author":"Chen","year":"2023","journal-title":"Neuropharmacology"},{"issue":"41","key":"10.1016\/j.bcp.2025.117238_b0570","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000500895","article-title":"Administration of a 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor Improves Outcome in a Rat Model of Pediatric Traumatic Brain Injury","volume":"3\u20134","author":"Shu","year":"2019","journal-title":"Dev. Neurosci."},{"issue":"47","key":"10.1016\/j.bcp.2025.117238_b0575","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1161\/STROKEAHA.116.015146","article-title":"20-hydroxyeicosatetraenoic acid as a predictor of neurological deterioration in acute minor ischemic stroke","volume":"12","author":"Yi","year":"2016","journal-title":"Stroke"},{"issue":"291","key":"10.1016\/j.bcp.2025.117238_b0580","doi-asserted-by":"crossref","first-page":"L378","DOI":"10.1152\/ajplung.00424.2005","article-title":"Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells","volume":"3","author":"Chen","year":"2006","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"issue":"298","key":"10.1016\/j.bcp.2025.117238_b0585","doi-asserted-by":"crossref","first-page":"L564","DOI":"10.1152\/ajplung.00298.2009","article-title":"20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase\/Akt","volume":"4","author":"Bodiga","year":"2010","journal-title":"Am. J. Physiol.-Lung Cell. Mol. Physiol."},{"issue":"296","key":"10.1016\/j.bcp.2025.117238_b0590","doi-asserted-by":"crossref","first-page":"H777","DOI":"10.1152\/ajpheart.01087.2008","article-title":"20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells","volume":"3","author":"Dhanasekaran","year":"2009","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"318","key":"10.1016\/j.bcp.2025.117238_b0595","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.yexcr.2012.06.005","article-title":"Tissue protection and endothelial cell signaling by 20-HETE analogs in intact ex vivo lung slices","volume":"16","author":"Jacobs","year":"2012","journal-title":"Exp. Cell Res."},{"issue":"122","key":"10.1016\/j.bcp.2025.117238_b0600","article-title":"Prophylactic supplementation of 20-HETE ameliorates hypoxia\/reoxygenation injury in pulmonary vascular endothelial cells by inhibiting apoptosis","volume":"1","author":"Sugumaran","year":"2020","journal-title":"Acta Histochem."},{"issue":"402","key":"10.1016\/j.bcp.2025.117238_b0605","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.canlet.2017.05.030","article-title":"Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma","author":"Wang","year":"2017","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.bcp.2025.117238_b0610","article-title":"HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice","volume":"12","author":"Borin","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bcp.2025.117238_b0615","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12672-017-0299-0","article-title":"Role of 20-Hydroxyeicosatetraenoic Acid (20-HETE) in Androgen-Mediated Cell Viability in Prostate Cancer Cells","volume":"4","author":"Colombero","year":"2017","journal-title":"Horm. Cancer"},{"issue":"559","key":"10.1016\/j.bcp.2025.117238_b0620","article-title":"20-HETE\/GPR75 pairing modulates the expression and transcriptional activity of the androgen receptor in androgen-sensitive prostate cancer cells","author":"Cardenas","year":"2023","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117238_b0625","doi-asserted-by":"crossref","unstructured":"S. Cardenas, C. Colombero, L. Panelo, R. Dakarapu, J.R. Falck, M.A. Costas, et al. GPR75 receptor mediates 20-HETE-signaling and metastatic features of androgen-insensitive prostate cancer cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2 (1865) (2020), p.158573.","DOI":"10.1016\/j.bbalip.2019.158573"},{"issue":"307","key":"10.1016\/j.bcp.2025.117238_b0630","doi-asserted-by":"crossref","first-page":"R693","DOI":"10.1152\/ajpregu.00422.2013","article-title":"Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition","volume":"6","author":"Zhang","year":"2014","journal-title":"Am. J. Physiol.-Regul. Integr. Comp. Physiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117238_b0635","article-title":"HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model","volume":"6","author":"Borin","year":"2017","journal-title":"PLoS One"},{"issue":"280","key":"10.1016\/j.bcp.2025.117238_b0640","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.taap.2014.07.018","article-title":"Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion","volume":"1","author":"Zheng","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"52","key":"10.1016\/j.bcp.2025.117238_b0645","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/dmd.123.001463","article-title":"Deciphering the Role of Fatty Acid-Metabolizing CYP4F11 in Lung Cancer and its potential As a Drug Target","volume":"2","author":"Jia","year":"2024","journal-title":"Drug Metab. Dispos."},{"issue":"21","key":"10.1016\/j.bcp.2025.117238_b0650","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1097\/00004647-200112000-00003","article-title":"Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia","volume":"12","author":"Gasche","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"133","key":"10.1016\/j.bcp.2025.117238_b0655","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.bjp.0704101","article-title":"HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme","volume":"3","author":"Miyata","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"284","key":"10.1016\/j.bcp.2025.117238_b0660","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-3565(24)37347-1","article-title":"Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors","volume":"3","author":"Wang","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"314","key":"10.1016\/j.bcp.2025.117238_b0665","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/jpet.105.083964","article-title":"Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke","volume":"1","author":"Miyata","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"29","key":"10.1016\/j.bcp.2025.117238_b0670","article-title":"19-Hydroxyeicosatetraenoic acid analogs: Antagonism of 20-hydroxyeicosatetraenoic acid-induced vascular sensitization and hypertension","volume":"19","author":"Dakarapu","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"277","key":"10.1016\/j.bcp.2025.117238_b0675","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"5","author":"Alonso-Galicia","year":"1999","journal-title":"Am. J. Phys. Anthropol."},{"issue":"87","key":"10.1016\/j.bcp.2025.117238_b0680","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.RES.87.1.60","article-title":"Production of 20-HETE and its role in autoregulation of cerebral blood flow","volume":"1","author":"Gebremedhin","year":"2000","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117238_b0685","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/713774023","article-title":"Altered mechanisms underlying hypoxic dilation of skeletal muscle resistance arteries of hypertensive versus normotensive Dahl rats","volume":"2","author":"Frisbee","year":"2001","journal-title":"Microcirculation"},{"issue":"15","key":"10.1016\/j.bcp.2025.117238_b0690","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41598-025-85992-2","article-title":"20-HETE mediates Ang II-induced cardiac hypertrophy via ROS and Ca(2+) signaling in H9c2 cells","volume":"1","author":"Han","year":"2025","journal-title":"Sci. Rep."},{"issue":"82","key":"10.1016\/j.bcp.2025.117238_b0695","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/0008-5472.CAN-21-4029","article-title":"CYP4F2-Catalyzed Metabolism of Arachidonic Acid Promotes Stromal Cell-Mediated Immunosuppression in Non-Small Cell Lung Cancer","volume":"21","author":"Chen","year":"2022","journal-title":"Cancer Res."},{"issue":"80","key":"10.1016\/j.bcp.2025.117238_b0700","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/FJC.0000000000001265","article-title":"Activation of GPR75 Signaling Pathway Contributes to the effect of a 20-HETE Mimetic, 5,14-HEDGE, to prevent Hypotensive and Tachycardic responses to Lipopolysaccharide in a Rat Model of Septic shock","volume":"2","author":"Tunctan","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"50","key":"10.1016\/j.bcp.2025.117238_b0705","first-page":"7","article-title":"20-Hydroxyeicosatetraenoic Acid Regulates the Src\/EGFR\/NF-kappaB Signaling Pathway Via GPR75 to Activate Microglia and Promote TBI in the Immature Brain","volume":"1","author":"Ma","year":"2024","journal-title":"Neurochem. Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:35:37Z","timestamp":1761381337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":141,"alternative-id":["S0006295225005039"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117238","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"20-HETE: Its potential role in physiological and pathophysiological processes","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117238"}}